On the contrary, Tregs primarily rely on oxidative phosphorylation [28], implying that cyclin G2 potentially exerts an antitumor role in glioma by reversing the acidic TME, in consideration of the inhibition of glycolysis by cyclin G2. Here, CCNG2 is linked to glioma.